patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: question to Craig Bird and his answer below on recent pps decline

a small holding. My only reason for the comments I made were to balance the sheet with those to whom I recommended this company. Note I did not say stock. I buy companies. I truly believe, as I'm sure you do, that this technology could save many lives and be a blessing to mankind. That is why I invested and why I recommended it to friends. Since I did recommend it to friends, I felt obliged to say something when I felt circumstances changed. I truly hope this company is successful and believe they will be long term. In the short term, however, they definitely shook my confidence with the billion share deal and reverse split. They have the technology to be successful. The question is do they have the short term news to offset the negatives. Please don't judge me too harshly.

Kikr

Share
New Message
Please login to post a reply